Skip To Main Content
Ignazio Barbagallo on Muck Rack

Ignazio Barbagallo

As seen in: Harm Reduction Journal, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ignazio

Contact Ignazio, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Anthocyanin Effects on Vascular and Endothelial Health: Evidence from Clinical Trials and Role of Gut Microbiota Metabolites

|
By Justyna Godos, Ignazio Barbagallo, Cinzia Lucia Randazzo, Samuele Laudani
| MDPI
1. Introduction Hypertension, also known as high blood pressure (BP), is an important public health issue affecting approximately 1 billion people globally [1]. Hypertension is a leading risk factor for cardiovascular disease (CVD) and a major contributor to the burden of disease worldwide [2]. Elevated BP has been estimated to be responsible for approximately 7.5 million deaths and 127.5 million disability-adjusted life years each year [3].
Open in Who Shared Issue with article?

Nanostructured Lipid Carriers Aimed to the Ocular Delivery of Mangiferin: In Vitro Evidence

|
By Debora Santonocito, Ignazio Barbagallo, Alfio Distefano, Giuseppe Sferrazzo
| MDPI
Abstract : Although mangiferin (MGN) is a natural antioxidant that could be a good candidate for the treatment of ocular diseases, its use in ophthalmology is strongly compromised due to its high lipophilicity. Its encapsulation in nanostructured lipid carriers (NLC) seems to be an interesting strategy for improving its ocular bioavailability. As reported in our previous work, MGN–NLC showed high ocular compatibility and fulfilled the nanotechnological requirements needed for ocular delivery.
Open in Who Shared Issue with article?

Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes

|
By Salvatore Alaimo, Renée O’Leary, Carmelina Daniela Anfuso, Ignazio Barbagallo
| Harm Reduction Journal Verified
Abstract Background In preparation for the 2021 revision of the European Union Tobacco Products Directive, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has posted its Preliminary Opinion on Electronic Cigarettes. They concluded that e-cigarettes only achieve a sub-optimal level of protection of human health.
Open in Who Shared Issue with article?
See all 3 articles